RC
BOLD

Rangeley Capital’s Boundless Bio BOLD Stock Holding History

Rangeley Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Buy
+74,000
New +$114K 0.17% 126

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Rangeley Capital's BOLD Position: Q2 2026 in Review

Rangeley Capital opened a new position in Boundless Bio (BOLD) in Q2 2026: 74,000 shares worth $185K. The stake represents 0.17% of the portfolio and ranks #126 among its holdings.

40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Rangeley Capital held 74,000 shares of Boundless Bio worth $185K as of Q2 2026.
  • Boundless Bio was a new Rangeley Capital position in Q2 2026.
  • Boundless Bio made up 0.17% of Rangeley Capital's portfolio in Q2 2026, its #126 holding.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.